Alnylam Pharmaceuticals | Денежные Средства И Эквиваленты



Cash And Equivalent Изменить Дата
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
Agios Pharmaceuticals USD 76.25M 177.48M 2024-12
Alnylam Pharmaceuticals USD 966.43M 133.49M 2024-12
Amgen USD 11.97B 2.96B 2024-12
Arrowhead Research USD 51.79M 47.4M 2024-12
BioMarin Pharmaceutical USD 613.22M 324.54M 2024-12
Incyte USD 2.41B 720.83M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Moderna USD 1.93B 283M 2024-12
Neurocrine Biosciences USD 233M 116.1M 2024-12
Novartis USD 11.46B 2.15B 2024-12
PTC Therapeutics USD 779.71M 253.71M 2024-12
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Sanofi 7.44B 646M 2024-12
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
Takeda JPY 494.13B 364.89B 2024-12
Tectonic Therapeutic USD 141.24M 17.86M 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Xencor USD 40.88M 11.84M 2024-12



Alnylam Pharmaceuticals Денежные Средства И Эквиваленты - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - May 2025.